Special Issue

The Role of Antibody Mediated Rejection in Organ Transplantation

Submission Deadline: November 15, 2025 (Open) Submit Now

Guest Editors

Milagros D. Samaniego-Picota, MD, FACP, FASN

Professor of Medicine, Internal Medicine – Nephrology, University of Michigan, 1500 E. Medical Center Drive, 3914 Taubman Center, Ann Arbor, MI 48109-5364, USA

Website | E-Mail

Research Interests: antibody-mediated rejection; management of highly sensitized and high risk kidney transplant recipients; densensitization protocols and ABO incompatible transplantation

Muhammad Mujtaba, MD, FASN, FAST

Associate Professor of Clinical Medicine, Division of Nephrology, University of Texas Medical Branch Galveston, Texas, USA

Website | E-Mail

Research Interests: pancreas transplantation; kidney transplantation; transplant surgery; organ donation; transplant immunology

Manuscript Submission Information

Manuscripts should be submitted through the LIDSEN Submission System. Detailed information on manuscript preparation and submission is available in the Instructions for Authors. All submitted articles will be thoroughly refereed through a single-blind peer-review process and will be processed following the Editorial Process and Quality Control policy. Upon acceptance, the article will be immediately published in a regular issue of the journal and will be listed together on the special issue website, with a label that the article belongs to the Special Issue. LIDSEN distributes articles under the Creative Commons Attribution (CC BY 4.0) License in an open-access model. The authors own the copyright to the article, and the article can be free to access, distribute, and reuse provided that the original work is correctly cited.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). Research articles and review articles are highly invited. Authors are encouraged to send the tentative title and abstract of the planned paper to the Editorial Office (transplantation@lidsen.com) for record. If you have any questions, please do not hesitate to contact the Editorial Office.

Welcome your submission!

Publication

Open Access Review Novel Therapies for the Treatment of Antibody Mediated Rejection in Solid Organ Transplantation: A Systematic Review by Alisia Chen  and Jeong M. Park Received: 29 October 2025;  Published: 24 February 2026;  doi: 10.21926/obm.transplant.2601267 Abstract Antibody mediated rejection (AMR) is a considerable cause of late allograft failure in solid organ transplantation. Conventional approaches, using plasmapheresis, intravenous immunoglobulin, rituximab, bortezomib, and eculizumab have been unsuccessful in improving graft survival. This review aims to assess emerging therapies for AMR treatment [...]